sodium citrate, anhydrous has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, JA; Andrade, LAS; Baptista, AL; de Brito, GA; Imanishe, MH; Moura, EIM; Pereira, BJ | 1 |
| Chen, H; Ding, B; Li, J; Li, X; Lin, J; Ma, P; Meng, Q; Tan, J; Zheng, P | 1 |
1 trial(s) available for sodium citrate, anhydrous and Neoplasms
| Article | Year |
|---|---|
Efficacy and Safety of Regional Anticoagulation with 4% Trisodium Citrate Versus Heparin in Extended Hemodialysis among Critical Patients with Cancer and Acute Kidney Injury.
Topics: Acute Kidney Injury; Aged; Citrates; Female; Heparin; Humans; Intensive Care Units; Male; Middle Aged; Neoplasms; Renal Dialysis; Retrospective Studies | 2021 |
1 other study(ies) available for sodium citrate, anhydrous and Neoplasms
| Article | Year |
|---|---|
Sodium Citrate Nanoparticles Induce Dual-Path Pyroptosis for Enhanced Antitumor Immunotherapy through Synergistic Ion Overload and Metabolic Disturbance.
Topics: Biomarkers, Tumor; Gasdermins; Humans; Immunotherapy; Intracellular Signaling Peptides and Proteins; Ions; Nanoparticles; Neoplasms; Pore Forming Cytotoxic Proteins; Pyroptosis; Sodium Citrate | 2023 |